Avicenna.AI secures FDA clearance for AI detection of vertebral compression fractures
Avicenna.AI receives approval for algorithms enabling incidental detection of pulmonary embolism and automatic assessment of stroke severity.
Avicenna.AI secures two FDA clearances for Stroke Assessment and opportunistic PE
Avicenna.AI receives approval for algorithms enabling incidental detection of pulmonary embolism and automatic assessment of stroke severity.
Blackford integrates CINA-iPE for opportunistic pulmonary embolism detection
La Ciotat, FRANCE – February 15, 2024 – Avicenna.AI, a French medical imaging AI specialist, is proud to announce a strategic partnership with AI platform pioneers Blackford to integrate its CINA-iPE, a CE-marked solution, into the Blackford AI Platform. This collaboration represents a significant step forward in the field of healthcare AI, offering healthcare professionals […]
ConcertAI’s TeraRecon partners with Avicenna.AI for AI-driven chest care coordination.
CAMBRIDGE, Mass., 01/11/2023 – ConcertAI’s TeraRecon, a leader in advanced visualization and AI Clinical SaaS, is pleased to announce an expanded collaboration with Avicenna.AI, a specialist in medical imaging AI. Together, they will provide global solutions that leverage artificial intelligence to enhance care coordination and improve patient triage for individuals afflicted with pulmonary embolism (PE) […]
ConcertAI’s TeraRecon and Avicenna.AI Partner on AI for Incidental Pulmonary Embolism
Medical imaging AI companies collaborate to offer CINA-iPE on TeraRecon’s Eureka Clinical AI platform. Cambridge, Mass., March 13, 2023 – ConcertAI’s TeraRecon, the advanced visualization and AI Clinical SaaS category leader, today announced a partnership to offer medical imaging AI specialist Avicenna.AI‘s CINA-iPE solution detecting the presence of incidental pulmonary embolisms as part of TeraRecon’s Eureka Clinical […]
Avicenna.AI launches AI solution for incidental pulmonary embolism detection
Medical imaging company to introduce CINA-iPE – the first tool in its new AI suite for incidental findings – at ECR 2023. Marseille, FRANCE – February 22, 2023 – Medical imaging AI specialist Avicenna.AI today announced the launch of CINA-iPE, a CE-marked AI tool that analyzes images from CT scans for the presence of incidental […]
Incepto Collaborates with Avicenna.AI to improve stroke management in Europe
Paris, France. February 13th, 2023 – Incepto, distributor, and co-creator of artificial intelligence (AI) solutions applied to medical imaging, signs a partnership with Avicenna.AI, developer of AI solutions for Radiology, and enriches its platform with new solutions for neurovascular pathologies such as stroke. All of these solutions are CE-cleared, and two are FDA marked. These […]
Avicenna.AI Lands Series A Funding to Fuel Global Growth, Bringing Total Investment to $10 Million
Medical imaging AI company brings total investment to $10 million and targets global growth.
Avicenna.AI partners with CARPL.ai on AI to detect life-threatening conditions
Avicenna.AI’s advanced AI detection tools are now available via the CARPL platform. Marseille, FRANCE – November 22, 2022 – Medical imaging AI specialist Avicenna.AI todayannounced a distribution agreement with CARPL.ai, a technology platform that enables service provider-oriented testing, validation and deployment of AI applications to healthcare providers. As the number of AI applications coming into […]
Avicenna.AI collaborates with deepc to revolutionize Stroke Patient Care
Marseille, FRANCE – September, 27, 2022. Medical imaging specialist Avicenna.AI today announced a groundbreaking partnership with the MedTech company deepc, offering one of the leading radiology AI platforms (deepcOS), to give healthcare providers access to their stroke suite. This move facilitates a step change in patient management for stroke, enabling rapid treatment decisions by combining […]